[
  {
    "ts": null,
    "headline": "CVS Health Corp. stock rises Monday, still underperforms market",
    "summary": "CVS Health Corp. stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=03d7e97cce9f872d29ba1f6a644f3986ca187817eebc9d021860aef5e69b1f74",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736182260,
      "headline": "CVS Health Corp. stock rises Monday, still underperforms market",
      "id": 132329045,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=03d7e97cce9f872d29ba1f6a644f3986ca187817eebc9d021860aef5e69b1f74"
    }
  },
  {
    "ts": null,
    "headline": "CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?",
    "summary": "CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the resumption of member redeterminations.",
    "url": "https://finnhub.io/api/news?id=f845a8bfa8257046e7b4ae2ca49334114cb3066e90e964490e8c9a98a0de6921",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736176920,
      "headline": "CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?",
      "id": 132289266,
      "image": "https://media.zenfs.com/en/zacks.com/6e1287c0c07b8954404037d468ef01ec",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the resumption of member redeterminations.",
      "url": "https://finnhub.io/api/news?id=f845a8bfa8257046e7b4ae2ca49334114cb3066e90e964490e8c9a98a0de6921"
    }
  },
  {
    "ts": null,
    "headline": "Is CVS Health Corporation (NYSE:CVS) the Best January Dividend Stock to Buy?",
    "summary": "We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other January dividend stocks. In 2024, dividend stocks fell short of investor expectations, largely due to the continuing AI boom and a heightened […]",
    "url": "https://finnhub.io/api/news?id=84ad2ea1b1ee0f3b5641d32c9fd87a96c10fef7c495d29c82fd7541c2267caaa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736175377,
      "headline": "Is CVS Health Corporation (NYSE:CVS) the Best January Dividend Stock to Buy?",
      "id": 132289267,
      "image": "https://s.yimg.com/ny/api/res/1.2/d6hiuhfSWIMOKtD72OdXqQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other January dividend stocks. In 2024, dividend stocks fell short of investor expectations, largely due to the continuing AI boom and a heightened […]",
      "url": "https://finnhub.io/api/news?id=84ad2ea1b1ee0f3b5641d32c9fd87a96c10fef7c495d29c82fd7541c2267caaa"
    }
  },
  {
    "ts": null,
    "headline": "What The Fed Will Do After December 2024's Non-Farm Payrolls Report",
    "summary": "The upcoming nonfarm payroll report for December 2024 may show continued job growth. Read my thoughts on the number of Fed rate cuts in 2025.",
    "url": "https://finnhub.io/api/news?id=d4804dc331379656e0d84a840f675c28262ea050f4e1ef1c51686f28c0d2bc1a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736172329,
      "headline": "What The Fed Will Do After December 2024's Non-Farm Payrolls Report",
      "id": 132289576,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1393736657/image_1393736657.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The upcoming nonfarm payroll report for December 2024 may show continued job growth. Read my thoughts on the number of Fed rate cuts in 2025.",
      "url": "https://finnhub.io/api/news?id=d4804dc331379656e0d84a840f675c28262ea050f4e1ef1c51686f28c0d2bc1a"
    }
  },
  {
    "ts": null,
    "headline": "CVS Pharmacy achieves CVS CostVantage milestone",
    "summary": "Delivering on the promise of a simpler, more transparent, and more sustainable approach to retail pharmacy services, CVS Health® (NYSE: CVS) today announced that all of the commercial prescriptions dispensed through CVS Pharmacy® are contracted through the company's innovative CVS CostVantage reimbursement model starting this year.",
    "url": "https://finnhub.io/api/news?id=fa8970738d960647c7dfd5905a6c563e92b84cd6dd8fe026386cbf1267359d47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736168400,
      "headline": "CVS Pharmacy achieves CVS CostVantage milestone",
      "id": 132289268,
      "image": "https://media.zenfs.com/en/prnewswire.com/a36c51c34c468155e15f8fa0a51f2cb8",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Delivering on the promise of a simpler, more transparent, and more sustainable approach to retail pharmacy services, CVS Health® (NYSE: CVS) today announced that all of the commercial prescriptions dispensed through CVS Pharmacy® are contracted through the company's innovative CVS CostVantage reimbursement model starting this year.",
      "url": "https://finnhub.io/api/news?id=fa8970738d960647c7dfd5905a6c563e92b84cd6dd8fe026386cbf1267359d47"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Stocks Are Down and Out. Opportunities Abound.",
    "summary": "Donald Trump’s election win prompted even more bullishness in a stock market that was already up significantly for the year.  For healthcare investors, though, it represented yet another reason to dump some stock.  Trump’s appointment of industry skeptics like  Robert F. Kennedy Jr.,  alongside broader expectations of a Republican crackdown on programs like Medicaid and Obamacare, has prompted a selloff in everything from hospitals to pharmaceuticals, health insurers and biotech.",
    "url": "https://finnhub.io/api/news?id=5ecfaab583f6fb045d9a38e85ba1f30c96ba7ed3da5389896f8a76e88f3a43da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736164800,
      "headline": "Healthcare Stocks Are Down and Out. Opportunities Abound.",
      "id": 132285420,
      "image": "",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Donald Trump’s election win prompted even more bullishness in a stock market that was already up significantly for the year.  For healthcare investors, though, it represented yet another reason to dump some stock.  Trump’s appointment of industry skeptics like  Robert F. Kennedy Jr.,  alongside broader expectations of a Republican crackdown on programs like Medicaid and Obamacare, has prompted a selloff in everything from hospitals to pharmaceuticals, health insurers and biotech.",
      "url": "https://finnhub.io/api/news?id=5ecfaab583f6fb045d9a38e85ba1f30c96ba7ed3da5389896f8a76e88f3a43da"
    }
  }
]